Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.

An array of isoforms of the nuclear estrogen receptor alpha (ER-α) protein contribute to heterogeneous response in breast cancer (BCa); yet, a single-cell analysis tool that distinguishes the full-length ER-α66 protein from the activation function-1 deficient ER-α46 isoform has not been reported. Sp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: John J Kim, Wenchuan Liang, Chi-Chih Kang, Mark D Pegram, Amy E Herr
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9775623135fe4148b38d349814c57b13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9775623135fe4148b38d349814c57b13
record_format dspace
spelling oai:doaj.org-article:9775623135fe4148b38d349814c57b132021-12-02T20:06:24ZSingle-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.1932-620310.1371/journal.pone.0254783https://doaj.org/article/9775623135fe4148b38d349814c57b132021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254783https://doaj.org/toc/1932-6203An array of isoforms of the nuclear estrogen receptor alpha (ER-α) protein contribute to heterogeneous response in breast cancer (BCa); yet, a single-cell analysis tool that distinguishes the full-length ER-α66 protein from the activation function-1 deficient ER-α46 isoform has not been reported. Specific detection of protein isoforms is a gap in single-cell analysis tools, as the de facto standard immunoassay requires isoform-specific antibody probes. Consequently, to scrutinize hormone response heterogeneity among BCa tumor cells, we develop a precision tool to specifically measure ER-α66, ER- α46, and eight ER-signaling proteins with single-cell resolution in the highly hetero-clonal MCF-7 BCa cell line. With a literature-validated pan-ER immunoprobe, we distinguish ER-α66 from ER-α46 in each individual cell. We identify ER-α46 in 5.5% of hormone-sensitive (MCF-7) and 4.2% of hormone-insensitive (MDA-MB-231) BCa cell lines. To examine whether the single-cell immunoblotting can capture cellular responses to hormones, we treat cells with tamoxifen and identify different sub-populations of ER-α46: (i) ER-α46 induces phospho-AKT at Ser473, (ii) S6-ribosomal protein, an upstream ER target, activates both ER-α66 and ER-α46 in MCF-7 cells, and (iii) ER-α46 partitions MDA-MB-231 subpopulations, which are responsive to tamoxifen. Unlike other single-cell immunoassays, multiplexed single-cell immunoblotting reports-in the same cell-tamoxifen effects on ER signaling proteins and on distinct isoforms of the ER-α protein.John J KimWenchuan LiangChi-Chih KangMark D PegramAmy E HerrPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254783 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
John J Kim
Wenchuan Liang
Chi-Chih Kang
Mark D Pegram
Amy E Herr
Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
description An array of isoforms of the nuclear estrogen receptor alpha (ER-α) protein contribute to heterogeneous response in breast cancer (BCa); yet, a single-cell analysis tool that distinguishes the full-length ER-α66 protein from the activation function-1 deficient ER-α46 isoform has not been reported. Specific detection of protein isoforms is a gap in single-cell analysis tools, as the de facto standard immunoassay requires isoform-specific antibody probes. Consequently, to scrutinize hormone response heterogeneity among BCa tumor cells, we develop a precision tool to specifically measure ER-α66, ER- α46, and eight ER-signaling proteins with single-cell resolution in the highly hetero-clonal MCF-7 BCa cell line. With a literature-validated pan-ER immunoprobe, we distinguish ER-α66 from ER-α46 in each individual cell. We identify ER-α46 in 5.5% of hormone-sensitive (MCF-7) and 4.2% of hormone-insensitive (MDA-MB-231) BCa cell lines. To examine whether the single-cell immunoblotting can capture cellular responses to hormones, we treat cells with tamoxifen and identify different sub-populations of ER-α46: (i) ER-α46 induces phospho-AKT at Ser473, (ii) S6-ribosomal protein, an upstream ER target, activates both ER-α66 and ER-α46 in MCF-7 cells, and (iii) ER-α46 partitions MDA-MB-231 subpopulations, which are responsive to tamoxifen. Unlike other single-cell immunoassays, multiplexed single-cell immunoblotting reports-in the same cell-tamoxifen effects on ER signaling proteins and on distinct isoforms of the ER-α protein.
format article
author John J Kim
Wenchuan Liang
Chi-Chih Kang
Mark D Pegram
Amy E Herr
author_facet John J Kim
Wenchuan Liang
Chi-Chih Kang
Mark D Pegram
Amy E Herr
author_sort John J Kim
title Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
title_short Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
title_full Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
title_fullStr Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
title_full_unstemmed Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
title_sort single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/9775623135fe4148b38d349814c57b13
work_keys_str_mv AT johnjkim singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer
AT wenchuanliang singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer
AT chichihkang singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer
AT markdpegram singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer
AT amyeherr singlecellimmunoblottingresolvesestrogenreceptoraisoformsinbreastcancer
_version_ 1718375375251177472